MIR4277

Across TCGA pan-cancer cohorts, MIR4277 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4277 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4277 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4277 expression acts as an unfavorable survival marker, although some lineages such as HNSC and TGCT show a favorable association.

STAD, COAD, and GBM are the cancer types where MIR4277 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.115	0.508	<.001	117	view →
COAD	DFS	Tertile	All	0.170	0.694	<.001	111	view →
GBM	OS	Tertile	All	0.042	0.416	<.001	54	view →
THCA	OS	Tertile	II,III,IV	0.884	0.972	.004	45	view →
KIRC	OS	Tertile	All	0.598	0.886	.006	18	view →
UCEC	OS	Tertile	All	0.725	0.927	.022	18	view →
ACC	OS	Tertile	All	0.653	0.850	.025	10	view →
HNSC	OS	Tertile	III,IV	0.688	0.310	.033	6	view →
TGCT	DFS	Tertile	All	1.000	0.625	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4277–STAD (DFS)

Open the STAD breakdown →